SQUAMOUS CELL CARCINOMA

This adverse event was reported 9423 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA:

# Drug Count
0 METHOTREXATE SODIUM 754
1 PREDNISONE 730
2 ADALIMUMAB 705
3 METHOTREXATE 689
4 INFLIXIMAB 599
5 TACROLIMUS 522
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 458
7 TACROLIMUS OINTMENT 0.1% 458
8 ETANERCEPT 457
9 ASPIRIN 438
See all common drugs associated with SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VEMURAFENIB 239 0.0199
1 ACITRETIN 68 0.0138
2 VISMODEGIB 111 0.0124
3 ERGOCALCIFEROL 353 0.0119
4 VORICONAZOLE 225 0.0073
5 GOLIMUMAB 92 0.0073
6 SIROLIMUS 90 0.0066
7 BASILIXIMAB 74 0.0062
8 HYDROXYUREA 129 0.0060
9 RUXOLITINIB 326 0.0045
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA